Cognitive deficits in schizophrenia and other neuropsychiatric disorders: Convergence of preclinical and clinical evidence

Cognitive deficits in schizophrenia and other neuropsychiatric disorders: Convergence of preclinical and clinical evidence
Author: Ales Stuchlik
Publisher: Frontiers Media SA
Total Pages: 285
Release: 2015-10-23
Genre: Neurosciences
ISBN: 2889196798

Neuropsychiatric diseases, such as schizophrenia, Alzheimer's disease, and etc., represent a serious medical and socioeconomic problems. These diseases are often accompanied by impairments of cognitive function, e.g., abstract thinking, decision-making, attention, and several types of memory. Such deficits significantly disrupt quality of life and daily functioning of patients. Cognitive deficits in neuropsychiatric diseases are associated with alterations of brain morphology and function, and are often resistant to therapeutic interventions. In schizophrenia and related disorders, cognitive deficits are also defined as endophenotypes, i.e. measurable phenotypes linking these disaeses with discrete heritable and reproducible traits. This points to the importance of elucidating these endophenotypes in translational studies. Animal models may not mimic the full spectrum of clinical symptoms, but may act as analogies of particular behaviors or other pathological outcomes. They are useful to search for the etiology of particular psychiatric illnesses and novel therapeutics. Moreover, several behavioral tests to measure cognitive performance in rodents and other species have been implemented. The primary focus of the present topic is to provide up-to-date information on cognitive deficits of neuropsychiatric disorders, such as schizophrenia. This Research Topic also delineates future directions for translational studies aimed at developing novel treatments/interventions of cognitive disturbances.

Cannabis

Cannabis
Author: Marco Colizzi
Publisher: MDPI
Total Pages: 204
Release: 2021-02-05
Genre: Science
ISBN: 3039439952

Over the years, there has been increasing interest into the public health impact of cannabis use, especially by young adults. This follows the evidence of a growing prevalence of regular cannabis use worldwide, with approximately 200 million users. Recreational cannabis use, especially a frequent use of products with high levels of its main psychoactive ingredient delta-9-tetrahydrocannabinol (Δ 9-THC), can cause dependence and have transient and long-lasting detrimental mental health effects, also negatively impacting cognitive processing and brain function and metabolism. In regular users, the development of tolerance to some of the effects of cannabis, especially the pleasurable ones, may lead to progressively heavier use in order to obtain the same effects in terms of their intensity, with higher health risks. However, the Cannabis Sativa plant contains different chemicals with different potential effects. In this regard, cannabidiol has gained interest because of its potential therapeutic properties, in line with evidence that CBD and Δ9-THC may exhibit opposite effects at the cannabinoid receptor type 1 (CB1), Δ9-THC being a partial agonist and CBD an antagonist/inverse agonist. Different cannabinoids may modulate human brain function and behavior in different ways, with different risk–benefit profiles.

The Adenosine Receptors

The Adenosine Receptors
Author: Pier Andrea Borea
Publisher: Humana Press
Total Pages: 603
Release: 2018-07-28
Genre: Medical
ISBN: 3319908081

This book traces the history of adenosine receptor research from molecular biology to medicinal chemistry to behavior, including their implications in disease and potential strategies as therapeutic targets. It provides the reader with a comprehensive overview of the adenosine receptors that includes information on all subtypes - A1, A2A, A2B and A3. Aspects addressed include the most up to date information on their functional distribution in the nervous and peripheral systems, behavioral roles in inflammation, cancer, pain and neurological diseases such as Huntington’s disease, Epilepsy, Parkinson’s disease and Alzheimer’s disease.

Late Onset Schizophrenia

Late Onset Schizophrenia
Author: Robert Howard
Publisher: Routledge
Total Pages: 296
Release: 1999
Genre: Medical
ISBN:

Schizophrenia, which starts in middle age or late life, has been described as 'the darkest area of psychiatry.' It is certainly controversial, with much disagreement about cut-off ages, diagnostic criteria and nomenclature. The contributors to this unique and very important book represent views from Europe and North America as well as Australia, Japan, and Nepal; they come from backgrounds of clinical practice and research. The contributors and editors were motivated by common aims: to review current international knowledge about late onset schizophrenia, to debate issues of heterogenity, gender, brain maturation and aging, putative structural and functional cerebral substrates for psychosis, to reach consensus on diagnosis and terminology, and to future research directions. The resulting book is an unqualified success which as well as being invaluable in old age psychiatry, sheds light on all aspects of schizophrenia treatment and research.

The Neurobiology of the Prefrontal Cortex

The Neurobiology of the Prefrontal Cortex
Author: Richard E. Passingham
Publisher: OUP Oxford
Total Pages: 424
Release: 2012-07-12
Genre: Medical
ISBN: 0191633097

The prefrontal cortex makes up almost a quarter of the human brain, and it expanded dramatically during primate evolution. The Neurobiology of the Prefrontal Cortex presents a new theory about its fundamental function. In this important new book, the authors argue that primate-specific parts of the prefrontal cortex evolved to reduce errors in foraging choices, so that particular ancestors of modern humans could overcome periodic food shortages. These developments laid the foundation for working out problems in our imagination, which resulted in the insights that allow humans to avoid errors entirely, at least at times. In the book, the authors detail which parts of the prefrontal cortex evolved exclusively in primates, how its connections explain why the prefrontal cortex alone can perform its function, and why other parts of the brain cannot do what the prefrontal cortex does. Based on an analysis of its evolutionary history, the book uses evidence from lesion, imaging, and cell-recording experiments to argue that the primate prefrontal cortex generates goals from a current behavioural context and that it can do so on the basis of single events. As a result, the prefrontal cortex uses the attentive control of behaviour to augment an older general-purpose learning system, one that evolved very early in the history of animals. This older system learns slowly and cumulatively over many experiences based on reinforcement. The authors argue that a new learning system evolved in primates at a particular time and place in their history, that it did so to decrease the errors inherent in the older learning system, and that severe volatility of food resources provided the driving force for these developments. Written by two leading brain scientists, The Neurobiology of the Prefrontal Cortex is an important contribution to our understanding of the evolution and functioning of the human brain.

Cognitive Impairment in Schizophrenia

Cognitive Impairment in Schizophrenia
Author: Philip D. Harvey
Publisher: Cambridge University Press
Total Pages: 341
Release: 2013-01-24
Genre: Medical
ISBN: 1107013208

Provides state-of-the-art information about cognition in schizophrenia with a wide ranging focus on measuring and treating cognitive deficits.

Cognition in Schizophrenia

Cognition in Schizophrenia
Author: Tonmoy Sharma
Publisher:
Total Pages: 382
Release: 2000
Genre: Medical
ISBN:

Although it has been known for 100 years that cognitive functioning is impaired in schizophrenia, the implications of this impairment have only recently been clearly understood. While in the past, cognitive deficits were thought to be the result of other aspects of the illness, such as poor co-operation, or as a result of the treatment of the illness, it is now known that these factors exert only a very minor influence on cognitive deficit. This book, with contributions from the major international names in the field, reviews the most recent research on the impairment of cognitive functioning in schizophrenia, covering: what it is, how wide-ranging it can be, what the clinical implications are, and how it can be treated? A detailed insight into cognitive deficit is the key to understanding why previous treatments have failed, and the key by which new treatments may change this terrible illness, treatments significantly more effective than earlier interventions.